CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals announced today that Company executives will present a corporate overview at the 15th Annual Needham Healthcare Conference. The presentation will take place at 3 p.m. on April 12 at the Westin New York Grand Central Hotel in New York City.
About Syros Pharmaceuticals
Syros Pharmaceuticals is a
biopharmaceutical company applying a pioneering approach to discover and
develop medicines that control the expression of genes with the aim of
treating cancer and other serious diseases. Syros has built a
proprietary gene control platform that provides the Company with a
unique lens to identify crucial genes that become dysregulated in
diseased cells. Syros is leveraging its platform to develop a pipeline
of gene control product candidates that it believes will provide a
profound and durable benefit for patients. The Company’s scientific
founders are world-class leaders in gene control research and
translation. Launched by Flagship Ventures and ARCH Venture Partners,
Syros Pharmaceuticals is located in Cambridge, Mass.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160406005414/en/
Media Contact:
Ten Bridge Communications, Inc.
Naomi
Aoki, 617-283-4298
naomi@tenbridgecommunications.com
or
Investor
Contact:
Stern Investor Relations, Inc.
Jesse Baumgartner,
212-362-1200
jesse@sternir.com
Source: Syros Pharmaceuticals
Released April 6, 2016